It’s Not East Being Green: The FDA’s Duties Under NEPA and ESA When Approving New Drugs and Biological Products
Harvard Environmental Law Review
Publication
August 5, 2024
Please visit Harvard Environmental Law Review to view this article.
Related Practices
YOU MIGHT ALSO LIKE
Florida’s rapid population growth and continued business migration have created extraordinary pressure on infrastructure, but they have also opened the door to significant opportunities for private developers willing to think beyond traditional procurement models.
A Florida appellate ruling reinforces that domicile depends on intent and facts—not location alone—making proactive estate, tax, and immigration planning critical for international families.
Florida's condominiums and HOAs face converging pressures from stalled legislation, new Fannie Mae and Freddie Mac lending standards, and proposed reforms to the state's condominium termination statute.
